Antiretroviral Therapy | Category | Clarifications/Special considerations |
---|---|---|
a) Nucleoside reverse transcriptase inhibitors (NRTIs) | No assigned category | Giving antiretroviral medications (ARVs) to either the HIV-positive mother or the HIV-exposed infant or both can significantly reduce the risk of transmitting HIV through breastfeeding. Read More |
Abacavir (ABC) | ||
Tenofovir (TDF) | ||
Zidovudine (AZT) | ||
Lamivudine (3TC) | ||
Didanosine (DDI) | ||
Emtricitabine (FTC) | ||
Stavudine (D4T) | ||
b) Non-nucleoside reverse transcriptase inhibitors (NNRTIs) | ||
Efavirenz (EFV) | ||
Etravirine (ETR) | ||
Nevirapine (NVP) | ||
Rilpivirine (RPV) | ||
c) Protease inhibitors (PIs) |
||
Ritonavir-boosted atazanavir (ATV/r) | ||
Ritonavir-boosted lopinavir (LPV/r) | ||
Ritonavir-boosted darunavir (DRV/r) | ||
Ritonavir (RTV) | ||
d) Integrase inhibitors | ||
Raltegravir (RAL) |